Overview
Share price change
24h
Current
Min
6.92
Max
6.97
Recommendations | Sell |
|---|---|
12 Months Forecast | +29.31% upside |
Next Earnings | 5 lis 2026 |
|---|
News Sentiment
By Acuity
100%
0%
327 / 340 Ranking in Healthcare
Ginkgo Bioworks Holdings Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
28 sie 2026, 22:02 UTC
Ginkgo Bioworks Holdings Inc shares are higher in after-market trading, continuing a recent trend of daily gains despite no specific news to explain the move.
Read
26 sie 2026, 20:08 UTC
Ginkgo Bioworks Holdings Inc is lower today, influenced by declines in the Life Sciences Tools & Services sub-sector and trading below its 20-day moving average.
Read
25 sie 2026, 20:07 UTC
Ginkgo Bioworks shares advance amid positive sentiment linked to Moderna and Merck. Earlier, shares pulled back from a session high but gained traction.
Read
24 sie 2026, 20:02 UTC
Ginkgo Bioworks shares are lower today amid broader market volatility and geopolitical concerns, with no specific company news identified to explain the decline.
Read
21 sie 2026, 23:56 UTC
Ginkgo Bioworks Holdings Inc is higher in after-market trading amid a broader market rebound, despite no specific company news identified.
Read
20 sie 2026, 23:41 UTC
Ginkgo Bioworks Holdings Inc. gained in after-market trading, supported by broader market movements and positive jobless claims data. Shares remain below their 20-day moving average.
Read
19 sie 2026, 23:51 UTC
Ginkgo Bioworks Holdings Inc shares are lower in after-market trading. The stock is also below its 20-day moving average.
Read
17 sie 2026, 19:46 UTC
Ginkgo Bioworks is advancing amid positive market sentiment following a rise in New York manufacturing conditions. Shares pulled back slightly after reaching a session high.
Read
14 sie 2026, 19:46 UTC
Ginkgo Bioworks Holdings Inc shares are lower amid broader market declines following a surprising drop in U.S. retail sales for July.
Read
11 sie 2026, 20:02 UTC
Ginkgo Bioworks shares are lower, tracking the broader market's decline. The stock remains below its 20-day moving average after four consecutive sessions of losses.
Read
10 sie 2026, 19:26 UTC
Ginkgo Bioworks reported second-quarter revenue of $20 million, a 48% decline year-over-year. Shares are trading lower, extending a three-day decline.
Read
7 sie 2026, 22:26 UTC
Ginkgo Bioworks shares decline in after-market hours following TD Cowen's downgrade to Hold and a price target cut to $9.
Read
6 sie 2026, 20:02 UTC
Ginkgo Bioworks is down significantly today, continuing a decline since Wednesday's close, despite recent operational improvements and a brief recovery earlier in the session.
Read
5 sie 2026, 22:51 UTC
Ginkgo Bioworks shares are lower in after-market trading following a revenue miss of $20 million, despite an EPS beat of -$0.92.
Read
4 sie 2026, 19:46 UTC
Ginkgo Bioworks shares are higher today, continuing a four-session rally, supported by broader market trends and easing inflation concerns from falling crude oil prices.
Read
3 sie 2026, 20:04 UTC
Ginkgo Bioworks Holdings Inc. is up notably since Friday's close, reflecting strong performance amid broader market gains, despite a slight pullback earlier in the session.
Read
31 lip 2026, 23:16 UTC
Ginkgo Bioworks shares are lower in after-market hours, reflecting broader market weakness and challenges in the specialty chemicals sector.
Read
29 lip 2026, 19:47 UTC
Ginkgo Bioworks has signed a $2.3 million deal with Thermo Fisher for 11 chips. Shares are declining amid broader market weakness and economic uncertainties.
Read
28 lip 2026, 22:46 UTC
Ginkgo Bioworks Holdings Inc. shares are lower in after-market hours, continuing a downward trend amid broader market weakness ahead of the Federal Reserve's policy meeting.
Read
27 lip 2026, 20:51 UTC
Ginkgo Bioworks shares are higher in after-market hours, supported by broader market trends as European indices, including the DAX, also rise.
Read
24 lip 2026, 19:07 UTC
Ginkgo Bioworks participates in the $400 million Genesis Mission but shares are lower amid broader market declines influenced by falling crude oil prices.
Read
21 lip 2026, 17:36 UTC
Ginkgo Bioworks Holdings Inc. is higher today, recovering from a session low, and has gained since Monday amid a broader market uptrend.
Read
Peer Comparison
Price change
Ginkgo Bioworks Holdings Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 9 USD 29.31%
High 9 USD
Low 9 USD
Based on 2 Wall Street analysts offering 12 month price targets forGinkgo Bioworks Holdings Inc - Dist in the last 3 months.
Rating Consensus
By TipRanks
Sell
2 ratings
0
Buy
1
Hold
1
Sell
Based on 2 analysts giving stock ratings to Ginkgo Bioworks Holdings Inc - Dist in the past 3 months.
Financials
$